These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20808934)

  • 1. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
    Fellenberg J; Kunz P; Sähr H; Depeweg D
    PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
    Li HX; Meng QP; Liu W; Li YG; Zhang HM; Bao FC; Song LL; Li HJ
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3038-44. PubMed ID: 25392102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxymatrine induces apoptosis in human cervical cancer cells through guanine nucleotide depletion.
    Li M; Su BS; Chang LH; Gao Q; Chen KL; An P; Huang C; Yang J; Li ZF
    Anticancer Drugs; 2014 Feb; 25(2):161-73. PubMed ID: 24231526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of drug-regulated genes in osteosarcoma cells.
    Fellenberg J; Dechant MJ; Ewerbeck V; Mau H
    Int J Cancer; 2003 Jul; 105(5):636-43. PubMed ID: 12740912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
    Li G; Zhu Y
    Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways.
    Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS
    Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
    Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
    Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.
    Hong L; Qiao T; Han Y; Han S; Zhang X; Lin T; Gao J; Zhao P; Chen Z; Fan D
    Biochem Cell Biol; 2006 Apr; 84(2):199-206. PubMed ID: 16609701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
    Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
    Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and biological analysis of Bcl-xL expression in human osteosarcoma.
    Wang ZX; Yang JS; Pan X; Wang JR; Li J; Yin YM; De W
    Bone; 2010 Aug; 47(2):445-54. PubMed ID: 20580954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPDH2 and HPRT expression and a prognostic significance in preoperative and postoperative patients with osteosarcoma.
    Chaiyawat P; Phanphaisarn A; Sirikaew N; Klangjorhor J; Thepbundit V; Teeyakasem P; Phinyo P; Pruksakorn D; Settakorn J
    Sci Rep; 2021 May; 11(1):10887. PubMed ID: 34035425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
    Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
    Elife; 2014 Oct; 3():. PubMed ID: 25347121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
    Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
    Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
    Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
    Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
    J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.